Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2012
11/01/2012WO2012038850A8 Pyrimidones for treatment of potassium channel related diseases
11/01/2012US20120277319 Use of Tapentadol for Inhibiting and/or Treating Depression and Anxiety
11/01/2012US20120277317 Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-related diseases
11/01/2012US20120277310 Novel conjugates for treating neurodegenerative diseases and disorders
11/01/2012US20120277304 Sodium transhinone iia sulfonate hydrate and preparation method and use thereof
11/01/2012US20120277297 Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors
11/01/2012US20120277292 ANTISENSE OLIGONUCLEOTIDES AGAINST cPLA2, COMPOSITIONS AND USES THEREOF
11/01/2012US20120277290 Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg
11/01/2012US20120277289 Activity generating delivery molecules
11/01/2012US20120277288 Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
11/01/2012US20120277279 Non-Steroidal Glucocorticoid Inhibitors and Their Use in Treating Inflammation, Allergy and Auto-Immune Conditions
11/01/2012US20120277273 Small molecule inhibitors of rgs proteins
11/01/2012US20120277272 Ethanamine Compounds and Methods of Using the Same
11/01/2012US20120277271 Methods and compositions
11/01/2012US20120277267 Method of managing or treating pain
11/01/2012US20120277265 Novel polyquinoline derivatives and the therapeutic use thereof
11/01/2012US20120277264 Antithrombotic agent
11/01/2012US20120277262 New aminotetraline derivatives
11/01/2012US20120277261 Pharmaceutical formulations useful in the treatment of insomnia
11/01/2012US20120277259 Substituted benzofused derivatives and their use as vanilloid receptor ligands
11/01/2012US20120277256 Frequency modulated drug delivery (fmdd)
11/01/2012US20120277253 Subcutaneous paliperidone composition
11/01/2012US20120277249 Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
11/01/2012US20120277248 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
11/01/2012US20120277244 Pyrazine derivatives and their use in the treatment of neurological disorders
11/01/2012US20120277243 Pyrazolidin-3-one derivatives
11/01/2012US20120277240 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
11/01/2012US20120277238 Pharmaceutical composition containing fused hetero-ring derivative
11/01/2012US20120277237 Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
11/01/2012US20120277228 Novel Azaheterocyclic Compounds
11/01/2012US20120277222 Treating various disorders using trkb agonists
11/01/2012US20120277221 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
11/01/2012US20120277220 5 OXO-5,8-DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS CAMKII KINASE INHIBITORS FOR TREATING CARDIOVASCULAR DISEASES
11/01/2012US20120277219 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/01/2012US20120277218 Methods and pharmaceutical compositions for treating down syndrome
11/01/2012US20120277216 1,2-dihydro-2-oxoquinoline compounds as 5-ht4 receptor ligands
11/01/2012US20120277214 Tricyclopyrazole derivatives
11/01/2012US20120277213 Ethynyl compounds
11/01/2012US20120277212 Novel Oxime Derivatives and Their Use As Allosteric Modulators of Metabotropic Glutamate Receptors
11/01/2012US20120277211 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype
11/01/2012US20120277209 Pyrazine compounds as phosphodiesterase 10 inhibitors
11/01/2012US20120277204 Pyridazinone compounds
11/01/2012US20120277203 Androstenediol as an indicator for assessing estrogenicity
11/01/2012US20120277196 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
11/01/2012US20120277190 Prodrugs of compounds that inhibit trpv1 receptor
11/01/2012US20120277186 Tricyclic Derivatives and Their Pharmaceutical Use and Compositions
11/01/2012US20120277180 Cofactors and Methods for Use for Individuals
11/01/2012US20120277171 Warmi®, natural alternative for the treatment of menopause
11/01/2012US20120277169 Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
11/01/2012US20120277167 Oral formulations of glycyl-2-methylprolyl-glutamate
11/01/2012US20120277166 Conotoxin peptides useful as inhibitors of neuronal amine transporters
11/01/2012US20120277160 Composition for improving brain function and method for improving brain function
11/01/2012US20120277159 Methods for treating depression using ncam peptide mimetics
11/01/2012US20120277158 Compositions and methods for the transport of therapeutic agents
11/01/2012US20120277156 Inhibition of pathological bone formation
11/01/2012US20120277146 Compounds For Enzyme Inhibition
11/01/2012US20120277142 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
11/01/2012US20120276225 Phytoestrogenic nutraceutical composition from palm leaf extract
11/01/2012US20120276216 Therapeutic Water Treatment
11/01/2012US20120276215 Therapeutic Conditioned Media
11/01/2012US20120276212 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
11/01/2012US20120276208 Acute cognitive and mood effects of plant polysaccharides in adult human subjects
11/01/2012US20120276203 Collagen matrix for cell therapy
11/01/2012US20120276202 Collagen matrix for tissue engineering
11/01/2012US20120276198 Pharmaceutical composition for treating parkinson's disease and preparation method thereof
11/01/2012US20120276196 Pharmaceutical Compositions of a Neuroactive Steroid and Methods of Use Thereof
11/01/2012US20120276195 Indole Alkaloid Derivatives Having Opioid Receptor Agonistic Effect, And Therapeutic Compositions And Methods Relating To Same
11/01/2012US20120276192 Compositions and methods for sirna inhibition of icam-1
11/01/2012US20120276191 Treatment and Diagnosis of Macrophage Mediated Disease
11/01/2012US20120276168 Amino acid conjugates of quetiapine, process for making and using the same
11/01/2012US20120276143 Probiotic bifidobacterium strain
11/01/2012US20120276116 Prevention and Treatment of Amyloidogenic Disease
11/01/2012US20120276114 Ifn-gamma inhibitors in the treatment of motoneuron diseases
11/01/2012US20120276102 Methods of treatment utiliziing binding proteins of the interleukin-21 receptor
11/01/2012US20120276076 Arf6 as a new target for treating alzheimer's disease
11/01/2012US20120276073 Treatment of nerve injuries
11/01/2012US20120276070 Induced Pluripotent Stem Cells and Related Methods
11/01/2012US20120276068 Method for treating chronic nerve tissue injury using a cell therapy strategy
11/01/2012US20120276067 Assay for the Prediction of Therapeutic Effectiveness of Mesenchymal Stromal Cells, and Methods of Using Same
11/01/2012US20120276066 Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same
11/01/2012US20120276063 Priming of pluripotent stem cells for neural differentiation
11/01/2012US20120276057 Nutritional composition for supporting brain development and function of toddlers
11/01/2012US20120276049 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
11/01/2012US20120276048 Extended treatment of multiple sclerosis
11/01/2012US20120276019 Tissue kallikrein for the treatment of parkinson's disease
11/01/2012US20120276017 Methods and Compositions for Treatment of Attention Deficit Disorder
11/01/2012US20120276009 Pharmaceutical composition
11/01/2012US20120275996 IL-1 Binding Proteins
11/01/2012CA2834735A1 Method of treating dyskinesia
11/01/2012CA2834548A1 Inhibitors of histone deacetylase
11/01/2012CA2834429A1 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity
11/01/2012CA2834387A1 Novel rock inhibitors
11/01/2012CA2834286A1 Methods of treating alzheimer's disease, huntington's disease, autism, and other disorders
11/01/2012CA2834280A1 Methods of administering anatabine to treat autism spectrum disorders and seizure disorders
11/01/2012CA2834274A1 Neurodegenerative disorders and muscle diseases implicating pufas
11/01/2012CA2834042A1 Acute cognitive and mood effects of plant polysaccharides in adult human subjects
11/01/2012CA2834028A1 Stable pharmaceutical composition
11/01/2012CA2833493A1 Amide compound and pharmaceutical application therefor
11/01/2012CA2833443A1 A composition of entacopone
11/01/2012CA2833304A1 Salt of an inhibitor of phoshodiesterase 10 enzyme
1 ... 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... 1833